Slowing the decline

Nature

Volumn 466, Issue 7310 SUPPL., 2010, Pages

  Williams, Ruth ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; LEVODOPA; NEURTURIN; PRAMIPEXOLE; RASAGILINE; SELEGILINE; TOCOPHEROL; UBIDECARENONE;

BRAIN; DISEASE TREATMENT; DRUG; EXPERIMENTAL STUDY; NERVOUS SYSTEM DISORDER;

BRAIN CORTEX; CEREBROSPINAL FLUID; CLINICAL TRIAL; DIET SUPPLEMENTATION; DOPAMINERGIC NERVE CELL; ELECTRON TRANSPORT; GENE THERAPY; HUMAN; MONOTHERAPY; MULTIPLE SCLEROSIS; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE; UNSPECIFIED SIDE EFFECT;

ANTIPARKINSON AGENTS; CLINICAL TRIALS AS TOPIC; CREATINE; HUMANS; INDANS; PARKINSON DISEASE; SELEGILINE; UBIQUINONE;

EID: 77956203125     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/466S13a     Document Type: Short Survey

References (13)

1. Moon, Y. et al. J. Neurochem. 93, 1199-1208 (2005).
2. Beal, M. F. et al. Brain Res. 783, 109-114 (1998).
3. S hults, C. W. et al. Arch. Neurol. 59, 1541-1550 (2002).
4. NIN DS NET-PD Investigators. Neurology 68, 20-28 (2007).
5. N utt, J. G. et al. Neurology 60, 69-73 (2003).
6. L ang, A. E. et al. Ann. Neurol. 59, 459-466 (2006).
7. M arks, W. J. Jr et al. Lancet Neurol. 7, 400-408 (2008).
8. Ward, C. D. J. Neurol. Neurosurg. Psychiatry 57, 217-220 (1994).
9. NIN DS NET-PD Investigators. Neurology 66, 664-671 (2006).
10. Fahn, S. J. Neural. Transm. 70 (suppl.), 419-426 (2006).
11. Schapira, A. et al. Parkinsonism Relat. Disord. 15 (suppl. 2), abstr. S81 (2009).
12. Parkinson Study Group. Arch. Neurol. 61, 561-566 (2004)
13. O lanow, C. W. et al. N. Engl. J. Med. 361, 1268-1278 (2009)